热门资讯> 正文
Aytu Bizerma宣布出售消费者健康业务
2024-08-06 20:54
- Aytu BioPharma (NASDAQ:AYTU) announced that following the wind down of operations, it has entered into a definitive agreement to divest its Consumer Health (a/k/a Innovus Pharmaceuticals) business to a private, e-commerce focused company.
- The divested business encompasses the established e-commerce platform, certain inventory and associated consumer brands, intellectual property, contracts and liabilities, and provides for Aytu to receive revenue-based royalty payments on future sales of former Consumer Health business products.
- Source: Press Release
More on Aytu BioScience
- Aytu BioPharma, Inc. (AYTU) Q3 2024 Earnings Call Transcript
- Aytu Biopharma announces paydown and refinancing of term loan
- Aytu BioPharma up 5% as quarterly results beat on both lines
- Seeking Alpha’s Quant Rating on Aytu BioScience
- Historical earnings data for Aytu BioScience
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
